The ability of NRF2 to promote PI3K‐mTOR pathway activity seems to be conserved across cell types, with cross‐talk being observed in multiple types of cancer cell lines, as well as normal cells such as melanocytes and hepatocytes.7, 18, 19, 21, 22, 23, 24. This evidence concerns the gene NFE2L2 and cancer.